|
Index of reports
> Cases with Confusional State ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Invega (Paliperidone) where reactions include confusional state. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Invega side effects in 70 year old female
Reported by a individual with unspecified qualification from United States on 2012-08-08
Patient: 70 year old female, weighing 68.0 kg (149.7 pounds)
Reactions: LIP Swelling, Movement Disorder, Confusional State, Restless Legs Syndrome, Reading Disorder, Thirst, Fatigue, Thinking Abnormal, Balance Disorder, Dysgraphia, Hypersomnia, Dysphagia, Partner Stress, Muscle Twitching, Dysarthria, Activities of Daily Living Impaired, Dysuria, Disturbance in Attention, Gait Disturbance, Asthenia, Feeling Abnormal
Drug(s) suspected as cause:
Invega
Dosage: 3x
Indication: Bipolar Disorder
Start date: 2012-07-02
Invega Sustenna
Dosage: 234 mg 2
Indication: Schizoaffective Disorder
Start date: 2012-07-05
End date: 2012-07-12
Possible Invega side effects in 46 year old female
Reported by a physician from Italy on 2012-07-26
Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Dysarthria, Confusional State, Agitation, Tachycardia, Miosis, Self Injurious Behaviour
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-18
End date: 2012-07-18
Cymbalta
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-18
End date: 2012-07-18
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-02
Patient: female, weighing 104.3 kg (229.5 pounds)
Reactions: Confusional State, Angina Pectoris, Pain in Extremity, Gastritis Erosive, Pain, Hypotension, Dyskinesia, Diplopia, Colonic Polyp, Abnormal Loss of Weight, Dizziness, Gallbladder Disorder, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Dosage: 3 week supply, once a day, 2-6 mg/1-3 mg every morning
Administration route: Oral
Indication: Schizoaffective Disorder
Start date: 2007-11-01
End date: 2012-02-01
Invega
Dosage: 3 week supply, once a day, 2-6 mg/1-3 mg every morning
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2007-11-01
End date: 2012-02-01
Other drugs received by patient: Citalopram Hydrobromide; Tramadol HCL; Hydrochlorothiazide; Clonazepam; Nasonex; Tekturna; Benicar HCT; Flovent HFA; Omeprazole; Aciphex; Ranitidine; Bystolic; Furosemide; Potassium; Lyrica; Levothyroxine Sodium; Naproxen; Aspirin; AN Unknown Medication; Trazodone HCL; Singulair; Benadryl
Possible Invega side effects in 28 year old male
Reported by a physician from United States on 2012-05-15
Patient: 28 year old male
Reactions: Confusional State, Blood Prolactin Increased, Blood Testosterone Decreased, Tremor
Drug(s) suspected as cause:
Invega
Other drugs received by patient: Neurontin; Depakote; Buspar; Trazodone HCL; ALL Other Therapeutic Drugs
Possible Invega side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-11
Patient: female, weighing 104.3 kg (229.5 pounds)
Reactions: Confusional State, Pain in Extremity, Angina Pectoris, Gastritis Erosive, Dyskinesia, Pain, Hypotension, Colonic Polyp, Diplopia, Abnormal Loss of Weight, Dizziness, Gallbladder Disorder, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Schizoaffective Disorder
End date: 2012-02-01
Invega
Administration route: Oral
Indication: Bipolar Disorder
End date: 2012-02-01
Possible Invega side effects in female
Reported by a physician from Italy on 2012-03-22
Patient: female
Reactions: Confusional State, Dysarthria, Hyperammonaemia, Antipsychotic Drug Level Above Therapeutic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lithium Carbonate
Administration route: Oral
Start date: 2011-12-06
End date: 2011-12-12
Depakene
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-05
End date: 2011-12-05
Depakene
Dosage: form strenght: 200mg
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-12
Invega
Administration route: Oral
Start date: 2011-12-12
End date: 2011-12-13
Depakene
Dosage: form strength; 500mg
Administration route: Oral
Start date: 2011-12-06
End date: 2011-12-10
Invega
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-07
End date: 2011-12-11
Lithium Carbonate
Dosage: daily: 600mg, 300mg days
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-05
End date: 2011-12-05
Other drugs received by patient: Delorazepam; Antipsychotics; Antipsychotics
Possible Invega side effects in female
Reported by a physician from Italy on 2012-03-22
Patient: female
Reactions: Confusional State, Dysarthria, Hyperammonaemia, Antipsychotic Drug Level Above Therapeutic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-07
End date: 2011-12-11
Antipsychotics
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-07
End date: 2011-12-11
Depakene
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-05
End date: 2011-12-05
Delorazepam
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-07
End date: 2011-12-13
Invega
Administration route: Oral
Start date: 2011-12-12
End date: 2011-12-13
Depakene
Dosage: form strenght: 200mg
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-12
Antipsychotics
Administration route: Oral
Start date: 2011-12-12
Depakene
Dosage: form strength; 500mg
Administration route: Oral
Start date: 2011-12-06
End date: 2011-12-10
Lithium Carbonate
Administration route: Oral
Start date: 2011-12-06
End date: 2011-12-12
Lithium Carbonate
Dosage: daily: 600mg, 300mg days
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-05
End date: 2011-12-05
Possible Invega side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-22
Patient: female
Reactions: Confusional State, Dysarthria, Antipsychotic Drug Level Increased, Hyperammonaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Delorazepam
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-07
End date: 2011-12-13
Invega
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-12
End date: 2011-12-13
Invega
Administration route: Oral
Start date: 2011-12-07
End date: 2011-12-11
Lithium Carbonate
Administration route: Oral
Start date: 2011-12-06
End date: 2011-12-12
Depakene
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-05
End date: 2011-12-05
Lithium Carbonate
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-05
End date: 2011-12-05
Depakene
Administration route: Oral
Start date: 2011-12-06
End date: 2011-12-10
Depakene
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-12
Possible Invega side effects in 53 year old female
Reported by a physician from United States on 2012-03-16
Patient: 53 year old female
Reactions: Confusional State, Adverse Drug Reaction, Mental Status Changes, Condition Aggravated, Disorientation, Treatment Noncompliance, Blood Sodium Abnormal, Asthenia, Lethargy, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega Sustenna
Indication: Schizophrenia
Start date: 2011-01-01
End date: 2011-11-01
Invega
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-11-01
End date: 2012-01-01
Possible Invega side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-14
Patient: female
Reactions: Confusional State, Dysarthria, Antipsychotic Drug Level Increased, Hyperammonaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lithium Carbonate
Administration route: Oral
Start date: 2011-12-06
End date: 2011-12-12
Delorazepam
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-07
End date: 2011-12-13
Depakene
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-06
End date: 2011-12-10
Depakene
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-12
Invega
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-12
End date: 2011-12-13
Invega
Administration route: Oral
Start date: 2011-12-07
End date: 2011-12-11
Lithium Carbonate
Administration route: Oral
Indication: Affective Disorder
Start date: 2011-12-05
End date: 2011-12-05
Depakene
Administration route: Oral
Start date: 2011-12-05
End date: 2011-12-05
Possible Invega side effects in female
Reported by a physician from Belgium on 2011-11-18
Patient: female
Reactions: Confusional State, Dehydration, Urinary Tract Infection, Extrapyramidal Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Invega
|
